Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ACADIA Pharmaceuticals Inc. (ACAD) had Weighted-Average Shares Outstanding (Diluted) of 167.67M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$244.32M |
|
$18.99M |
|
$20.39M |
|
$223.93M |
|
$225.03M |
|
$19.29M |
|
$8.49M |
|
$27.78M |
|
$27.78M |
|
$18.99M |
|
$18.99M |
|
$18.99M |
|
$18.99M |
|
$19.29M |
|
$20.12M |
|
166.81M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
167.67M |
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$870.94M |
|
$3.50M |
|
$261.42M |
|
$1.13B |
|
$302.53M |
|
-- |
|
$64.60M |
|
$367.13M |
|
$765.24M |
|
$648.18M |
|
$765.24M |
|
167.12M |
|
| Cash Flow Statement Financials | |
$20.32M |
|
$-124.05M |
|
$1.84M |
|
$328.36M |
|
$226.47M |
|
$-101.89M |
|
$11.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.65% |
|
7.90% |
|
7.90% |
|
-- |
|
11.37% |
|
7.77% |
|
$20.32M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.89 |
|
2.15 |
|
41.89 |
|
2.48% |
|
2.93% |
|
1.68% |
|
2.48% |
|
$4.58 |
|
$0.12 |
|
$0.12 |
|